Oncolink Features

Find My Cancer Drug

Tipos de Cancer / Cánceres del Hueso / Sarcoma de Ewing / Exámenes de Detección

Link to OncoLink

NCI CANCERLIT^® Search: Von Hippel-Lindau Syndrome - July 2002

Imprima English

National Cancer Institute^®
Ultima Vez Modificado: 1 de julio del 2002

Simultaneous development of pheochromocytomas in prepubertal siblings with von Hippel-Lindau syndrome.
Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
Early identification of patients with von Hippel-Lindau disease at risk for pheochromocytoma.

Table of Contents

1
UI - 12032534
AU - Franklin SL; Eisenhofer G; Geffner ME
TI - Simultaneous development of pheochromocytomas in prepubertal siblings with von Hippel-Lindau syndrome.
SO - J Pediatr 2002 May;140(5):625-8
AD - Division of Endocrinology, Department of Pediatrics, Mattel Children's Hospital at UCLA, Los Angeles, California 90095, USA.
We report 2 siblings with a known von Hippel-Lindau mutation who simultaneously developed asymptomatic pheochromocytomas at significantly younger ages than are typically seen in this setting.

2
UI - 11865075
AU - Wiesener MS; Eckardt KU
TI - Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
SO - Nephrol Dial Transplant 2002 Mar;17(3):356-9

3
UI - 12084291
AU - Maranchie JK; Walther MM
TI - Early identification of patients with von Hippel-Lindau disease at risk for pheochromocytoma.
SO - Curr Urol Rep 2001 Feb;2(1):24-30
AD - Urologic Oncology Branch, National Cancer Institute, 10101 Grosvenor Place, #518, North Bethesda, MD 20852, USA. Maranchj@mail.nih.gov
von Hippel-Lindau disease (VHL) is an autosomal dominant familial syndrome that predisposes to the formation of tumors in multiple organ systems, including adrenal and extra-adrenal pheochromocytomas. However, fewer than 30% of VHL families develop pheochromocytomas. In recent years, this clinical heterogeneity has been correlated with missense mutations. The VHL patient requires vigilant, lifelong biochemical and radiographic screening for pheochromocytoma. Half of VHL pheochromocytomas present bilaterally, and there is a high incidence of recurrence after surgery. Because of the morbidity of bilateral total adrenalectomy with subsequent steroid replacement therapy, the recent therapeutic trend has been toward observation and minimally invasive adrenal-sparing procedures.

The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.

OncoLink I wish u knew...

Providing sedation can be used when the pain from cancer is uncontrolled. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews

Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement